Literature DB >> 21190805

Identification of multiple constituents in the traditional Chinese medicine formula Sheng-Mai San and rat plasma after oral administration by HPLC-DAD-MS/MS.

Yan-Hui Wang1, Cong Qiu, Da-Wei Wang, Zheng-Fang Hu, Bo-Yang Yu, Dan-Ni Zhu.   

Abstract

Sheng-Mai San (SMS), a traditional Chinese medicine formula, has been used for the treatment of cardiovascular disease in Asia over long period of time. While its effectiveness has been confirmed by clinical use, its active chemical constituents remain unclear. In this paper, an HPLC-DAD-MS/MS method is described for the efficient and rapid identification of the chemical constituents in SMS extract. MS/MS fragmentation behavior of authentic compounds was proposed for aiding the structural identification of the components. A total of 53 compounds were identified or tentatively characterized by comparing their retention times, UV and MS spectra with those of authentic compounds or literature data. HPLC/UV and MS techniques were employed to screen for the potential bioactive components in rat plasma after oral administration of SMS. Twenty-five compounds including 14 prototype components and 11 metabolites were detected in dosed rat plasma compared with blank rat plasma. This identification and structural elucidation of the chemical constituents in the medicine formula and rat plasma may provide important experimental data for further pharmacological and clinical research.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190805     DOI: 10.1016/j.jpba.2010.11.034

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  19 in total

1.  Quality control and identification of steroid saponins from Dioscorea zingiberensis C. H. Wright by fingerprint with HPLC-ELSD and HPLC-ESI-Quadrupole/Time-of-fight tandem mass spectrometry.

Authors:  Xinxin Zhang; Jinru Liang; Jianli Liu; Ye Zhao; Juan Gao; Wenji Sun; Yoichiro Ito
Journal:  J Pharm Biomed Anal       Date:  2013-11-27       Impact factor: 3.935

2.  Metabolic profile of danshen in rats by HPLC-LTQ-Orbitrap mass spectrometry.

Authors:  Huan-Huan Pang; Mei-Fang Jiang; Qin-Hui Wang; Xiao-Ye Wang; Wei Gao; Zhi-Hao Tian; Jian-Mei Huang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Mar.       Impact factor: 3.066

3.  An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases.

Authors:  Fang Li; Yan-ni Lv; Yi-sha Tan; Kai Shen; Ke-feng Zhai; Hong-Lin Chen; Jun-ping Kou; Bo-yang Yu
Journal:  Acta Pharmacol Sin       Date:  2015-10-12       Impact factor: 6.150

4.  Shengmai Formula suppressed over-activated Ras/MAPK pathway in C. elegans by opening mitochondrial permeability transition pore via regulating cyclophilin D.

Authors:  Yan Liu; Dejuan Zhi; Menghui Li; Dongling Liu; Xin Wang; Zhengrong Wu; Zhanxin Zhang; Dongqing Fei; Yang Li; Hongmei Zhu; Qingjian Xie; Hui Yang; Hongyu Li
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

5.  Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission.

Authors:  Fang Li; Xiaoxue Fan; Yu Zhang; Lizhi Pang; Xiaonan Ma; Meijia Song; Junping Kou; Boyang Yu
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

Review 6.  Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine.

Authors:  Minghua Liu; Ge Zhao; Shousong Cao; Yangyang Zhang; Xiaofang Li; Xiukun Lin
Journal:  Front Pharmacol       Date:  2017-01-09       Impact factor: 5.810

7.  Second-order calibration applied to quantification of two active components of Schisandra chinensis in complex matrix.

Authors:  Xiao-Hua Zhang; Hai-Long Wu; Jian-Yao Wang; Yao Chen; Yong-Jie Yu; Chong-Chong Nie; Chao Kang; De-Zhu Tu; Ru-Qin Yu
Journal:  J Pharm Anal       Date:  2012-04-25

8.  A metabonomic study of cardioprotection of ginsenosides, schizandrin, and ophiopogonin D against acute myocardial infarction in rats.

Authors:  Miaomiao Jiang; Liyuan Kang; Yi Wang; Xiaoping Zhao; Xuan Liu; Lei Xu; Zheng Li
Journal:  BMC Complement Altern Med       Date:  2014-09-23       Impact factor: 3.659

9.  Effects of ophiopogonin B on the proliferation and apoptosis of SGC‑7901 human gastric cancer cells.

Authors:  Weiyue Zhang; Qiaoyan Zhang; Yiping Jiang; Feng Li; Hailiang Xin
Journal:  Mol Med Rep       Date:  2016-04-27       Impact factor: 2.952

10.  Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice.

Authors:  Cheng-Zhi Chai; Wei-Lan Mo; Xian-Fei Zhuang; Jun-Ping Kou; Yong-Qing Yan; Bo-Yang Yu
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.